R&D Incentives Awarded By FDA, Not Patents, Suggested In Health Affairs
Executive Summary
Policy efforts to balance incentives for research and development with free-market competition may be more successful if they focus on FDA regulation rather than the patent system, an article in the September/ October issue of Health Affairs suggests.